426 related articles for article (PubMed ID: 22418039)
1. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
Saslow D; Solomon D; Lawson HW; Killackey M; Kulasingam SL; Cain JM; Garcia FA; Moriarty AT; Waxman AG; Wilbur DC; Wentzensen N; Downs LS; Spitzer M; Moscicki AB; Franco EL; Stoler MH; Schiffman M; Castle PE; Myers ER; Chelmow D; Herzig A; Kim JJ; Kinney W; Herschel WL; Waldman J
J Low Genit Tract Dis; 2012 Jul; 16(3):175-204. PubMed ID: 22418039
[TBL] [Abstract][Full Text] [Related]
2. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
Saslow D; Solomon D; Lawson HW; Killackey M; Kulasingam SL; Cain J; Garcia FA; Moriarty AT; Waxman AG; Wilbur DC; Wentzensen N; Downs LS; Spitzer M; Moscicki AB; Franco EL; Stoler MH; Schiffman M; Castle PE; Myers ER; ; ;
Am J Clin Pathol; 2012 Apr; 137(4):516-42. PubMed ID: 22431528
[TBL] [Abstract][Full Text] [Related]
3. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
Saslow D; Solomon D; Lawson HW; Killackey M; Kulasingam SL; Cain J; Garcia FA; Moriarty AT; Waxman AG; Wilbur DC; Wentzensen N; Downs LS; Spitzer M; Moscicki AB; Franco EL; Stoler MH; Schiffman M; Castle PE; Myers ER;
CA Cancer J Clin; 2012; 62(3):147-72. PubMed ID: 22422631
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
Fontham ETH; Wolf AMD; Church TR; Etzioni R; Flowers CR; Herzig A; Guerra CE; Oeffinger KC; Shih YT; Walter LC; Kim JJ; Andrews KS; DeSantis CE; Fedewa SA; Manassaram-Baptiste D; Saslow D; Wender RC; Smith RA
CA Cancer J Clin; 2020 Sep; 70(5):321-346. PubMed ID: 32729638
[TBL] [Abstract][Full Text] [Related]
5. Testing for cervical cancer: new recommendations from the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology.
CA Cancer J Clin; 2012; 62(3):211-2. PubMed ID: 22418892
[No Abstract] [Full Text] [Related]
6. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
7. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
8. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
9. Cervical Colposcopy: Indications and Risk Assessment.
Burness JV; Schroeder JM; Warren JB
Am Fam Physician; 2020 Jul; 102(1):39-48. PubMed ID: 32603071
[TBL] [Abstract][Full Text] [Related]
10. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
11. Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.
Nayar R; Chhieng DC; Crothers B; Darragh TM; Davey DD; Eisenhut C; Goulart R; Huang EC; Tabbara SO
J Am Soc Cytopathol; 2020; 9(4):291-303. PubMed ID: 32565297
[TBL] [Abstract][Full Text] [Related]
12. Practice Bulletin No. 157 Summary: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Jan; 127(1):185-187. PubMed ID: 26695578
[TBL] [Abstract][Full Text] [Related]
13. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
[TBL] [Abstract][Full Text] [Related]
14. Making Sense of Cervical Cancer Screening Guidelines and Recommendations.
Davis M; Feldman S
Curr Treat Options Oncol; 2015 Dec; 16(12):55. PubMed ID: 26467929
[TBL] [Abstract][Full Text] [Related]
15. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Oct; 128(4):e111-e130. PubMed ID: 27661651
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
[TBL] [Abstract][Full Text] [Related]
17. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Munshi VN; Perkins RB; Sy S; Kim JJ
Am J Obstet Gynecol; 2022 Feb; 226(2):228.e1-228.e9. PubMed ID: 34547295
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women.
Dempster-Rivett K; Innes CR; Simcock BJ; Harker D; Williman JA; Van Der Griend RA; Whitehead M; Hibma M; Lawton BA; Fitzgerald P; Dudley NM; Petrich S; Faherty J; Bergzoll C; Eva L; Sadler L; Pather S; Wrede CD; Sykes PH
Am J Obstet Gynecol; 2020 Sep; 223(3):408.e1-408.e11. PubMed ID: 32109465
[TBL] [Abstract][Full Text] [Related]
20. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
Wright TC; Schiffman M; Solomon D; Cox JT; Garcia F; Goldie S; Hatch K; Noller KL; Roach N; Runowicz C; Saslow D
Obstet Gynecol; 2004 Feb; 103(2):304-9. PubMed ID: 14754700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
